放射性配体
前列腺癌
剂量学
谷氨酸羧肽酶Ⅱ
放射治疗
肿瘤科
前列腺
医学
癌症
内科学
核医学
受体
作者
Mahmood Kazemi-Jahromi,Elmira Yazdani,Najme Karamzade-Ziarati,Mahboobeh Asadi,Mahdi Sadeghi,Parham Geramifar
标识
DOI:10.1080/09553002.2024.2404448
摘要
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) is revolutionizing the treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) patients. This study aimed to establish patient-specific radiation dosimetry for [
科研通智能强力驱动
Strongly Powered by AbleSci AI